Zynerba Pharmaceuticals (ZYNE)

[Fress]

ZYNE will be getting fast tracked for multiple more indications this year DEE, ASD, 22q



Multiple expected near term milestones:


Initiate Phase 2 22q deletion syndrome this quarter we have a few days left.


Dee Results early Q3


Fragile X sometime in the second half on 2019 my estimation is July or August.



Assess other neuropsychiatric
conditions: in 2019


THC Biosynthetic Platform in the works this could be HUGE

The 3.0 Version of GWPH no reliance on the plant. Patented Biosynthetic platform ready to go Proven Team in place.



If you look at the share volume it continues to increase. Probably getting close to 100 million shares traded from the start of the year only 18 Million floating 21 Million Total shares and Insiders haven't sold a share even when we were higher a few years back. At this rate the ALL time high of 36.49 Will be taken sometime this year.


GWPH 5.4 Billion Market Cap
ZYNE 325 Million Market Cap



Read for yourself in black and white ZYNE latest company overview:
http://ir.zynerba.com/static-files/e772c9c3-7f37-4f0b-8844-d5a5e601cbf3


$ZYNE